Edwards Lifesciences Corp

SEGALL BRYANT & HAMILL, LLC EW

Report date

3/31/2026

Quarter

2026 Q1

Filed

5/15/2026

Shares

20,111

Value ($000)

1,711

Weight

0.0%

2013 Q4 - 2026 Q1 (19 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2026 Q1	5/15/2026	1,711	0.0%	20,111	3/31/2026
2023 Q3	11/9/2023	1,771	0.0%	25,561	9/30/2023
2023 Q2	8/14/2023	2,599	0.0%	27,557	6/30/2023
2023 Q1	5/15/2023	1,904	0.0%	23,024	3/31/2023
2022 Q4	2/14/2023	1,724	0.0%	23,117	12/31/2022
2022 Q3	11/14/2022	1,937	0.0%	23,417	9/30/2022
2022 Q2	8/15/2022	2,275	0.0%	23,949	6/30/2022
2022 Q1	5/13/2022	2,833	0.0%	24,084	3/31/2022
2021 Q4	2/14/2022	3,792	0.0%	29,261	12/31/2021
2021 Q3	11/3/2021	3,384	0.0%	29,863	9/30/2021
2021 Q2	8/12/2021	3,076	0.0%	29,743	6/30/2021
2021 Q1	5/13/2021	2,405	0.0%	28,749	3/31/2021
2020 Q4	2/12/2021	2,698	0.0%	29,556	12/31/2020
2020 Q3	11/13/2020	2,389	0.0%	29,931	9/30/2020
2020 Q2	8/14/2020	2,157	0.0%	31,206	6/30/2020
2020 Q1	5/14/2020	1,978	0.0%	10,471	3/31/2020
2019 Q4	2/11/2020	2,446	0.0%	10,471	12/31/2019
2014 Q1	5/14/2014	661	0.0%	8,910	3/31/2014
2013 Q4	2/5/2014	617	0.0%	9,390	12/31/2013